Kimberly Blackwell, M.D.

Kimberly Blackwell, M.D.

Former Chief Executive Officer and Interim Chief Medical OfficeratZentalis Pharmaceuticals· In proxies 2022–2024

Pay in FY2022Zentalis Pharmaceuticals stock -76.0% the same year

Kimberly Blackwell, M.D. was paid $36.6M in FY2022 (Dec). Zentalis Pharmaceuticals stock fell 76.0% that year.

Pay$100 in the stock at the end of FY21 → $24
Pay is from the Summary Compensation Table of each Zentalis Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Zentalis PharmaceuticalsPublic company · 4 yr
    • Former Chief Executive Officer and Interim Chief Medical Officer2022 – Present · 4 yrStock in role -97%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?